| pubmed-article:11822754 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0699903 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:11822754 | lifeskim:mentions | umls-concept:C1709518 | lld:lifeskim |
| pubmed-article:11822754 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:11822754 | pubmed:dateCreated | 2002-2-1 | lld:pubmed |
| pubmed-article:11822754 | pubmed:abstractText | Gemcitabine and paclitaxel are two of the most active agents in non-small-cell lung cancer (NSCLC), and pharmacologic investigation of the combination regimens including these drugs may offer a valuable opportunity in treatment optimization. The present study investigates the pharmacokinetics and pharmacodynamics of paclitaxel and gemcitabine in chemotherapy-naive patients with advanced NSCLC within a phase I study. | lld:pubmed |
| pubmed-article:11822754 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11822754 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11822754 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11822754 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11822754 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11822754 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11822754 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11822754 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11822754 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:Del TaccaMM | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:DanesiRR | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:De BraudFF | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:CuriglianoGG | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:FogliSS | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:De PasTT | lld:pubmed |
| pubmed-article:11822754 | pubmed:author | pubmed-author:GiovannettiGG | lld:pubmed |
| pubmed-article:11822754 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11822754 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:11822754 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11822754 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11822754 | pubmed:pagination | 1553-9 | lld:pubmed |
| pubmed-article:11822754 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:meshHeading | pubmed-meshheading:11822754... | lld:pubmed |
| pubmed-article:11822754 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11822754 | pubmed:articleTitle | Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer. | lld:pubmed |
| pubmed-article:11822754 | pubmed:affiliation | Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Italy. | lld:pubmed |
| pubmed-article:11822754 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11822754 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11822754 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11822754 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11822754 | lld:pubmed |
